Forest Laboratories, Inc.

909 Third Avenue,
New York, New York 10022
United States,
(212) 421-7850
www.frx.com

Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.4/yr) # 2 - 2 - - - 4
vol $1.7B $4.0B $5.7B
Sell (0.2/yr) # - - - 1 - - 1
  5

Top M&A Advisors

Financial Deals
Sign-up to View
2
Legal Deals
Sign-up to View
1
Sign-up to View
1
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Aptalis Pharma, Inc.
$2.9B (2014-01-08)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

Forest Laboratories was acquired by Allergan on February 18, 2014.

Forest Laboratories has acquired 6 companies of its own, including 3 in the last 5 years. A total of 4 acquisitions came from private equity firms. It has also divested 1 asset.

Forest Laboratories’ largest acquisition to date was in 2014, when it acquired Aptalis Pharma for $2.9B. Forest Laboratories has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (50%) and medical products (50%).

When analyzing the medical products sector as a whole, according to Mergr, in the last 3 years, there are 330 medical products companies that have made at least 1 acquisition, 17 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic medical products acquirer over the past 3 years is Medtronic, with 12 acquisitions. The most prolific private equity acquirer in the medical products sector over the past 3 years is SHS GmbH with 7 platform acquisitions.

Join Mergr and gain access to Forest Laboratories’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.